• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同模式的炎症和血管生成因子与腹膜透析患者的腹膜小分子转运和腹膜蛋白清除有关。

Different patterns of inflammatory and angiogenic factors are associated with peritoneal small solute transport and peritoneal protein clearance in peritoneal dialysis patients.

机构信息

Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, No.1630, Dongfang Road, Pudong New Area, Shanghai, 200127, China.

出版信息

BMC Nephrol. 2018 May 23;19(1):119. doi: 10.1186/s12882-018-0921-6.

DOI:10.1186/s12882-018-0921-6
PMID:29792163
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5966920/
Abstract

BACKGROUND

Both peritoneal small solute transport and peritoneal protein clearance are closely linked to outcomes in peritoneal dialysis (PD) patients. However, the associated factors of these two components are not fully understood so far. This study aimed to investigate the association between a panel of systemic and peritoneal inflammatory and angiogenic factors and peritoneal solute transport properties.

METHODS

Stable PD patients in PD center of Renji Hospital, School of Medicine, Shanghai Jiao Tong University were enrolled in present study. Serum and overnight effluent markers including angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), sTie-2, VEGF, IL-6 and IL-10 were determined. Mass transfer area coefficient of creatinine (MTACcr) and peritoneal protein clearance (Prcl) were calculated. Multivariable linear regression was used to examine the association between these markers and MTACcr as well as Prcl.

RESULTS

A total of 320 patients were enrolled in present study, which consisted of 166 (51.9%) males with a mean age of 56.8 ± 14.2 years and a median PD duration of 32.5 (9.0-56.3) months. Multiple regression analyses showed that BSA, history glucose exposure, dialysate IL-6 AR and dialysate Ang-1 AR were independent associated factors of MTACcr, while BSA and serum Ang-1 were independent associated factors of Prcl.

CONCLUSIONS

MTACcr representing peritoneal small-solute transport and Prcl representing peritoneal large molecular transport are associated with slightly different panels of inflammatory and angiogenic factors.

摘要

背景

腹膜小分子转运和腹膜蛋白清除率与腹膜透析(PD)患者的预后密切相关。然而,到目前为止,这两个组成部分的相关因素还不完全清楚。本研究旨在探讨一系列全身和腹膜炎症及血管生成因子与腹膜溶质转运特性之间的关系。

方法

本研究纳入了上海交通大学医学院仁济医院 PD 中心的稳定 PD 患者。测定了血清和隔夜流出液标志物,包括血管生成素-1(Ang-1)、血管生成素-2(Ang-2)、可溶性 Tie-2、VEGF、IL-6 和 IL-10。计算肌酐的质量转移面积系数(MTACcr)和腹膜蛋白清除率(Prcl)。采用多元线性回归分析这些标志物与 MTACcr 及 Prcl 的关系。

结果

本研究共纳入 320 例患者,其中男性 166 例(51.9%),平均年龄 56.8±14.2 岁,PD 病程中位数为 32.5(9.0-56.3)个月。多元回归分析显示,BSA、既往血糖暴露、透析液 IL-6 AR 和透析液 Ang-1 AR 是 MTACcr 的独立相关因素,而 BSA 和血清 Ang-1 是 Prcl 的独立相关因素。

结论

代表腹膜小分子转运的 MTACcr 和代表腹膜大分子转运的 Prcl 与略有不同的炎症和血管生成因子有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc7/5966920/2578f8960e0a/12882_2018_921_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc7/5966920/2578f8960e0a/12882_2018_921_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccc7/5966920/2578f8960e0a/12882_2018_921_Fig1_HTML.jpg

相似文献

1
Different patterns of inflammatory and angiogenic factors are associated with peritoneal small solute transport and peritoneal protein clearance in peritoneal dialysis patients.不同模式的炎症和血管生成因子与腹膜透析患者的腹膜小分子转运和腹膜蛋白清除有关。
BMC Nephrol. 2018 May 23;19(1):119. doi: 10.1186/s12882-018-0921-6.
2
Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients.腹腔内白细胞介素-6 系统是影响新进入腹膜透析患者基础腹膜溶质转运的重要决定因素。
Nephrol Dial Transplant. 2010 May;25(5):1639-46. doi: 10.1093/ndt/gfp670. Epub 2010 Jan 8.
3
Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients.新开始非糖尿病腹膜透析患者腹膜溶质转运率的决定因素。
Perit Dial Int. 2004 Nov-Dec;24(6):554-61.
4
Inflammatory factors for hypoalbuminemia in Japanese peritoneal dialysis patients.日本腹膜透析患者低白蛋白血症的炎症因素。
Nephrology (Carlton). 2013 Aug;18(8):539-44. doi: 10.1111/nep.12106.
5
Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study.新腹膜透析患者全身和局部腹膜炎症对腹膜溶质转运率的影响:一项为期 1 年的前瞻性研究。
Nephrol Dial Transplant. 2010 Jun;25(6):1964-73. doi: 10.1093/ndt/gfp767. Epub 2010 Jan 25.
6
A simple assessment of peritoneal transport in stable continuous ambulatory peritoneal dialysis patients.对稳定的持续性非卧床腹膜透析患者腹膜转运的简单评估。
Am J Nephrol. 1998;18(4):311-7. doi: 10.1159/000013356.
7
Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis.腹膜透析第一年期间的全身及腹腔内白细胞介素-6系统
Perit Dial Int. 2006 Jan-Feb;26(1):53-63.
8
Intraperitoneal interleukin-6 levels predict peritoneal solute transport rate: a prospective cohort study.腹腔内白细胞介素-6水平可预测腹膜溶质转运率:一项前瞻性队列研究。
Am J Nephrol. 2014;39(6):459-65. doi: 10.1159/000362622. Epub 2014 May 14.
9
Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent peritoneal dialysis patients.腹膜转运率、炎症及超滤对维持性腹膜透析患者营养状况和临床结局的影响
Perit Dial Int. 2003 Mar-Apr;23(2):174-83.
10
Evaluation of peritoneal transport properties at onset of peritoneal dialysis and longitudinal follow-up.腹膜透析开始时及纵向随访期间腹膜转运特性的评估。
Nephrol Dial Transplant. 2006 Apr;21(4):1032-9. doi: 10.1093/ndt/gfi344. Epub 2005 Dec 19.

引用本文的文献

1
Peritoneal protein clearance, fluid overload, and cardiovascular events in patients undergoing peritoneal dialysis: a prospective cohort study.腹膜透析患者的腹膜蛋白清除率、液体超负荷与心血管事件:一项前瞻性队列研究
Ren Fail. 2025 Dec;47(1):2461676. doi: 10.1080/0886022X.2025.2461676. Epub 2025 Feb 17.
2
The centre-calculated cutoff value is better for identifying fast peritoneal solute transfer of patients on peritoneal dialysis than the traditional value: a retrospective cohort study.与传统值相比,中心计算的截止值在识别腹膜透析患者快速腹膜溶质转运方面更具优势:一项回顾性队列研究。
Clin Kidney J. 2023 Aug 21;16(11):2023-2031. doi: 10.1093/ckj/sfad197. eCollection 2023 Nov.
3

本文引用的文献

1
Intraperitoneal interleukin-6 levels predict peritoneal solute transport rate: a prospective cohort study.腹腔内白细胞介素-6水平可预测腹膜溶质转运率:一项前瞻性队列研究。
Am J Nephrol. 2014;39(6):459-65. doi: 10.1159/000362622. Epub 2014 May 14.
2
Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival.全身和腹腔炎症对腹膜透析生存的独立影响。
J Am Soc Nephrol. 2013 Dec;24(12):2071-80. doi: 10.1681/ASN.2013030314. Epub 2013 Sep 5.
3
Peritoneal protein leakage, systemic inflammation, and peritonitis risk in patients on peritoneal dialysis.
Impact of different automated peritoneal dialysis modalities on the inflammatory profile of elderly patients with chronic kidney disease.
不同自动化腹膜透析模式对老年慢性肾脏病患者炎症谱的影响。
J Bras Nefrol. 2023 Jan-Mar;45(1):17-26. doi: 10.1590/2175-8239-JBN-2022-0005en.
4
Oxidative Stress-Induced Alterations of Cellular Localization and Expression of Aquaporin 1 Lead to Defected Water Transport upon Peritoneal Fibrosis.氧化应激诱导的水通道蛋白1细胞定位和表达改变导致腹膜纤维化时水转运缺陷。
Biomedicines. 2022 Mar 30;10(4):810. doi: 10.3390/biomedicines10040810.
5
Protective effect of COMP-angiopoietin-1 on peritoneal vascular permeability and peritoneal transport function in uremic peritoneal dialysis rats.COMP-血管生成素-1对尿毒症腹膜透析大鼠腹膜血管通透性及腹膜转运功能的保护作用
Am J Transl Res. 2019 Sep 15;11(9):5932-5943. eCollection 2019.
6
Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis.基因或药理学阻断增强子 of zeste 同源物 2 可抑制腹膜纤维化的进展。
J Pathol. 2020 Jan;250(1):79-94. doi: 10.1002/path.5352. Epub 2019 Nov 14.
腹膜透析患者的腹膜蛋白渗漏、全身炎症和腹膜炎风险。
Perit Dial Int. 2013 May-Jun;33(3):273-9. doi: 10.3747/pdi.2011.00326. Epub 2013 Jan 2.
4
Association between interleukin-10 gene polymorphism -592 (A/C) and peritoneal transport in patients undergoing peritoneal dialysis.白细胞介素-10 基因多态性 -592(A/C)与腹膜透析患者腹膜转运的关系。
Nephrology (Carlton). 2011 Sep;16(7):663-71. doi: 10.1111/j.1440-1797.2011.01496.x.
5
Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients.腹腔内白细胞介素-6 系统是影响新进入腹膜透析患者基础腹膜溶质转运的重要决定因素。
Nephrol Dial Transplant. 2010 May;25(5):1639-46. doi: 10.1093/ndt/gfp670. Epub 2010 Jan 8.
6
Factors contributing to peritoneal tissue remodeling in peritoneal dialysis.导致腹膜透析中腹膜组织重塑的因素。
Perit Dial Int. 2009 Nov-Dec;29(6):605-17.
7
Peritoneal protein clearance and not peritoneal membrane transport status predicts survival in a contemporary cohort of peritoneal dialysis patients.腹膜蛋白清除率而非腹膜转运状态可预测当代腹膜透析患者队列的生存率。
Clin J Am Soc Nephrol. 2009 Jul;4(7):1201-6. doi: 10.2215/CJN.01910309. Epub 2009 May 28.
8
Angiopoietin-1 reduces vascular endothelial growth factor-induced brain endothelial permeability via upregulation of ZO-2.血管生成素-1通过上调紧密连接蛋白2降低血管内皮生长因子诱导的脑内皮通透性。
Int J Mol Med. 2009 Feb;23(2):279-84.
9
Higher daily peritoneal protein clearance when initiating peritoneal dialysis is independently associated with peripheral arterial disease (PAD): a possible new marker of systemic endothelial dysfunction?开始腹膜透析时较高的每日腹膜蛋白清除率与外周动脉疾病(PAD)独立相关:这是全身内皮功能障碍的一个可能的新标志物吗?
Nephrol Dial Transplant. 2009 Mar;24(3):1009-14. doi: 10.1093/ndt/gfn595. Epub 2008 Nov 7.
10
The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus.Tie2受体拮抗剂血管生成素2促进系统性红斑狼疮中的血管炎症。
Ann Rheum Dis. 2009 Oct;68(10):1638-43. doi: 10.1136/ard.2008.094664. Epub 2008 Oct 17.